Per-Henrik Edqvist
Projektkoordinator vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Tobias Sjöblom
- Telefon:
- 018-471 48 15
- E-post:
- per-henrik.edqvist@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 37 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 Uppsala
- Akademiska meriter:
- M.SC. Ph.D. Associate professor
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Administrative director of U-CAN.
Publikationer
Senaste publikationer
- Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma (2024)
- Next generation pan-cancer blood proteome profiling using proximity extension assay (2023)
- An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers (2023)
- Combined expression of HOXA11 and CD10 identifies endometriosis versus normal tissue and tumors (2022)
- Noninvasive detection of any-stage cancer using free glycosaminoglycans (2022)
Alla publikationer
Artiklar
- Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma (2024)
- Next generation pan-cancer blood proteome profiling using proximity extension assay (2023)
- An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers (2023)
- Combined expression of HOXA11 and CD10 identifies endometriosis versus normal tissue and tumors (2022)
- Noninvasive detection of any-stage cancer using free glycosaminoglycans (2022)
- Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. (2022)
- The Immune Landscape of Colorectal Cancer (2021)
- The prognostic impact of the tumour stroma fraction (2021)
- CDX2 (2020)
- Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases (2020)
- Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy (2020)
- Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis (2020)
- Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors (2019)
- Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity (2019)
- Affibody-derived drug conjugates (2018)
- Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma (2018)
- Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions (2018)
- U-CAN (2018)
- Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma (2018)
- Integration of Transcriptomics and Antibody-Based Proteomics for Exploration of Proteins Expressed in Specialized Tissues (2018)
- Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence (2017)
- A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family (2017)
- Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma (2017)
- A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma (2017)
- EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model (2017)
- Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc. (2017)
- Targeting tumor cells based on Phosphodiesterase 3A expression (2017)
- Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients (2017)
- Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib (2017)
- Serglycin as a potential biomarker for glioma (2017)
- A pathology atlas of the human cancer transcriptome (2017)
- Horizontal Cells, the Odd Ones Out in the Retina, Give Insights into Development and Disease (2016)
- A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression (2016)
- SATB2 is expressed in Merkel cell carcinoma (2016)
- Heparanase Promotes Glioma Progression and is Inversely Correlated with Patient Survival. (2016)
- Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1 (2016)
- PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. (2016)
- The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene (2016)
- Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data (2016)
- Expression of Human Skin-Specific Genes Defined by Transcriptomics and Antibody-Based Profiling (2015)
- Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma (2015)
- FGF2 as a potential prognostic biomarker for proneural glioma patients (2015)
- Tissue-based map of the human proteome (2015)
- A study of embryonic stem cell-related proteins in human astrocytomas (2014)
- Detection of the human endogenous retrovirus ERV3-encoded Env-protein in human tissues using antibody-based proteomics (2014)
- A systematic analysis of commonly used antibodies in cancer diagnostics (2014)
- Subtyping of gliomas of various WHO grades by the application of immunohistochemistry (2014)
- Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner (2014)
- PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas (2014)
- Contribution of Antibody-based Protein Profiling to the Human Chromosome-centric Proteome Project (C-HPP) (2013)
- Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma (2013)
- STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer (2013)
- A Texture Based Pattern Recognition Approach to Distinguish Melanoma from Non-Melanoma Cells in Histopathological Tissue Microarray Sections (2013)
- Vandetanib combined with a p38 MAPK inhibitor synergistically reduces glioblastoma cell survival (2013)
- The protein phosphatase 2 subunit PR48 is a novel melanoma tumor suppressor gene. (2013)
- Antibodies for profiling the human proteome (2012)
- Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization (2012)
- Platelet-derived growth factor over-expression in retinal progenitors results in abnormal retinal vessel formation (2012)
- GABA-A Channel Subunit Expression in Human Glioma Correlates with Tumor Histology and Clinical Outcome (2012)
- The Human Protein Atlas as a proteomic resource for biomarker discovery (2011)
- Horizontal cell progenitors arrest in G2-phase and undergo terminal mitosis on the vitreal side of the chick retina (2009)
- Temporal and spatial expression of transcription factors FoxN4, Ptf1a, Prox1, Isl1 and Lim1 mRNA in the developing chick retina (2008)
- Axon-bearing and axon-less horizontal cell subtypes are generated consecutively during chick retinal development from progenitors that are sensitive to follistatin (2008)
- Newborn horizontal cells migrate bi-directionally across the neuroepithelium during retinal development (2004)
- Prognostic whole-genome and transcriptome signatures in colorectal cancers
Böcker
